世界科学技术-中医药现代化
世界科學技術-中醫藥現代化
세계과학기술-중의약현대화
WORLD SCIENCE AND TECHNOLOGY-MODERNIZATION OF TRADITIONAL CHINESE MEDICINE
2014年
12期
2593-2597
,共5页
褚福永%刘红旭%张大炜%陈嘉兴%尚菊菊%张竹华%周琦%李爱勇%田伟
褚福永%劉紅旭%張大煒%陳嘉興%尚菊菊%張竹華%週琦%李愛勇%田偉
저복영%류홍욱%장대위%진가흥%상국국%장죽화%주기%리애용%전위
参元益气活血胶囊%不稳定型心绞痛%冠脉介入术%生活质量
參元益氣活血膠囊%不穩定型心絞痛%冠脈介入術%生活質量
삼원익기활혈효낭%불은정형심교통%관맥개입술%생활질량
Shen-Y uan Y i-Qi Huo-Xue capsule%unstable angina%percutaneous coronary intervention%quality of life
目的:研究参元益气活血胶囊联合早期冠脉介入对不稳定型心绞痛患者近期生活质量的影响。方法:78例不稳定型心绞痛患者随机分为治疗组和对照组,各39例,冠状动脉造影后行早期冠状动脉介入治疗(PCI)术,术前对照组给予常规西药治疗,治疗组给予常规西药治疗加参元益气活血胶囊,每次3粒,每日3次,疗程30天。治疗前后对两组患者生活质量进行评分,判定心绞痛、心电图及中医主症疗效。结果:与治疗前相比,两组患者治疗后躯体活动受限程度、心绞痛稳定状态、心绞痛发作情况、治疗满意程度计分均明显升高(P<0.05);与对照组比较,参元益气活血胶囊治疗组治疗后心绞痛发作频率、持续时间以及心悸、乏力、气短症状均明显改善(P<0.05),治疗组心绞痛稳定状态、心绞痛发作情况、治疗满意程度计分均明显升高(P<0.05)。结论:参元益气活血胶囊联合早期PCI治疗可以提高不稳定型心绞痛患者的近期生活质量和中医主症。
目的:研究參元益氣活血膠囊聯閤早期冠脈介入對不穩定型心絞痛患者近期生活質量的影響。方法:78例不穩定型心絞痛患者隨機分為治療組和對照組,各39例,冠狀動脈造影後行早期冠狀動脈介入治療(PCI)術,術前對照組給予常規西藥治療,治療組給予常規西藥治療加參元益氣活血膠囊,每次3粒,每日3次,療程30天。治療前後對兩組患者生活質量進行評分,判定心絞痛、心電圖及中醫主癥療效。結果:與治療前相比,兩組患者治療後軀體活動受限程度、心絞痛穩定狀態、心絞痛髮作情況、治療滿意程度計分均明顯升高(P<0.05);與對照組比較,參元益氣活血膠囊治療組治療後心絞痛髮作頻率、持續時間以及心悸、乏力、氣短癥狀均明顯改善(P<0.05),治療組心絞痛穩定狀態、心絞痛髮作情況、治療滿意程度計分均明顯升高(P<0.05)。結論:參元益氣活血膠囊聯閤早期PCI治療可以提高不穩定型心絞痛患者的近期生活質量和中醫主癥。
목적:연구삼원익기활혈효낭연합조기관맥개입대불은정형심교통환자근기생활질량적영향。방법:78례불은정형심교통환자수궤분위치료조화대조조,각39례,관상동맥조영후행조기관상동맥개입치료(PCI)술,술전대조조급여상규서약치료,치료조급여상규서약치료가삼원익기활혈효낭,매차3립,매일3차,료정30천。치료전후대량조환자생활질량진행평분,판정심교통、심전도급중의주증료효。결과:여치료전상비,량조환자치료후구체활동수한정도、심교통은정상태、심교통발작정황、치료만의정도계분균명현승고(P<0.05);여대조조비교,삼원익기활혈효낭치료조치료후심교통발작빈솔、지속시간이급심계、핍력、기단증상균명현개선(P<0.05),치료조심교통은정상태、심교통발작정황、치료만의정도계분균명현승고(P<0.05)。결론:삼원익기활혈효낭연합조기PCI치료가이제고불은정형심교통환자적근기생활질량화중의주증。
This study was aimed to investigate the effects of Shen-Y uan Y i-Qi Huo-Xue (SYYQHX) capsule com-bined with early percutaneous coronary intervention (PCI) on near-term quality of life (QOL) in unstable angina (UA) patients. Seventy-eight patients diagnosed with UA were selected and randomly divided into the treatment group and control group, with 39 patients in each group. Early PCI was undergone after coronary angiography. Before PCI, the control group was given routine western medication. The treatment group was given routine western medication plus SYYQHX capsule, three pills once, three times daily. The treatment lasted for 30 days. The QOL scores were evalu-ated among patients from both groups before and after treatment in order to determine the efficacy on angina, electro-cardiogram (ECG) and traditional Chinese medicine (TCM) main symptom. The results showed that compared to pre-treatment, the scores of physical limitation (PL), angina stability (AS), angina frequency (AF), and treatment satisfac-tion ( TS ) were significantly increased after treatment ( P < 0 . 05 ) . Compared with the control group , after treat-ment with SYYQHX capsule, the AF, duration time and symptoms of palpitation, fatigue and shortness of breath were obviously improved (P< 0.05). The scores of AS, AF and TS in the treatment group were significantly increased (P < 0.05). It was concluded that SYYQHX capsule combined with early PCI can improve the near-term QOL and TCM main symptoms among UA patients.